Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation clinical trials

Explore recruiting acute leukemia with mixed lineage leukemia mll rearrangement or nucleophosmin 1 npm1 mutation clinical trials.

Recruiting acute leukemia with mixed lineage leukemia mll rearrangement or nucleophosmin 1 npm1 mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Open-Label, Dose-Escalation, Dose-Expansion Study of Enzomenib (DSP 5336) in Adult Patients with Acute Leukemia and Other Selected Hematologic Malignancies, with and without Mixed Lineage Leukemia (MLL) rearrangement or Nucleophosmin 1 (NPM1) Mutation

Spain, Belgium, France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation trials by city

Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Toronto Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Vancouver Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Montreal Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Calgary Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Edmonton Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Ottawa Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Winnipeg Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Quebec City Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Hamilton Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Kitchener Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in London Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Halifax Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in New York Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Los Angeles Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Chicago Acute Leukemia With Mixed Lineage Leukemia Mll Rearrangement Or Nucleophosmin 1 Npm1 Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease